New therapeutic hope is emerging for people with the rare inherited blistering skin disease recessive dystrophic epidermolysis bullosa (RDEB). Gurevich et al.1 have reported early-phase clinical trial data evaluating a topical herpes simplex virus 1 vector to restore missing type VII collagen in RDEB skin and heal wounds. Copyright © 2022 Elsevier Inc. All rights reserved.
Su M Lwin, John A McGrath. Restoring type VII collagen in skin. Med (New York, N.Y.). 2022 May 13;3(5):273-275
PMID: 35584643
View Full Text